Dietary Niacin Intake and Mortality in Nonalcoholic Fatty Liver Disease

Jie Pan,Yujia Zhou,Nengzhi Pang,Lili Yang
DOI: https://doi.org/10.1001/jamanetworkopen.2023.54277
2024-02-03
JAMA Network Open
Abstract:This cohort study analyzes data from the National Health and Nutrition Examination Survey to assess whether there is an association between dietary niacin intake and all-cause mortality or cardiovascular disease mortality among individuals with nonalcoholic fatty liver disease.
medicine, general & internal
What problem does this paper attempt to address?
### What problem does this paper attempt to solve? This paper aims to explore the relationship between dietary niacin (vitamin B3) intake and all - cause mortality and cardiovascular disease (CVD) mortality in patients with non - alcoholic fatty liver disease (NAFLD). Specifically, the main objectives of the study are: 1. **To evaluate the association between dietary niacin intake and all - cause mortality in NAFLD patients**: By analyzing large - scale prospective cohort data, researchers hope to determine whether high niacin intake is associated with a lower risk of all - cause mortality. 2. **To evaluate the association between dietary niacin intake and cardiovascular disease mortality in NAFLD patients**: Similarly, researchers hope to understand through data analysis whether high niacin intake has an impact on the mortality of cardiovascular diseases. ### Research background - **The global public health problem of NAFLD**: NAFLD is a common liver disease, affecting approximately 32.4% of the global population, and the prevalence is even higher in the United States, reaching 47.8%. The overall mortality rate of NAFLD patients is 15.4 cases per 1,000 person - years, and the number of deaths in NAFLD patients has doubled in the past three decades. - **Cardiovascular disease is the leading cause of death in NAFLD patients**: Among NAFLD patients, cardiovascular disease is the most important cause of death. Therefore, it is crucial to reduce the disease burden and mortality risk of NAFLD patients. - **The role of nutrition in health**: Niacin (vitamin B3), as a precursor of NAD (nicotinamide adenine dinucleotide) and NADP (nicotinamide adenine dinucleotide phosphate), plays an important role in cell metabolism, energy metabolism, and redox reactions. Although animal experiments have shown that niacin supplements can improve fatty liver, prior to this, there have been no prospective studies evaluating the relationship between dietary niacin intake and the mortality risk in NAFLD patients. ### Research methods - **Data sources**: The study used data from the National Health and Nutrition Examination Survey (NHANES) in the United States from 2003 to 2018, including a total of 4,315 NAFLD patients aged 20 years and older. - **Exposure factors**: Dietary niacin intake, measured by the two - 24 - hour dietary recall method. - **Main outcome measures**: All - cause mortality and cardiovascular disease mortality, estimated using weighted Cox proportional hazards models and restricted cubic splines. ### Main findings - **All - cause mortality**: Compared with the lowest tertile (≤18.4 mg/d), the highest tertile (≥26.7 mg/d) of dietary niacin intake was associated with a 30% reduction in all - cause mortality (adjusted HR = 0.70, 95% CI: 0.50 - 0.96, P = 0.03). - **Cardiovascular disease mortality**: There was no significant inverse association between dietary niacin intake and cardiovascular disease mortality (adjusted HR = 0.65, 95% CI: 0.35 - 1.20, P = 0.16). ### Conclusion The study results suggest that higher dietary niacin intake may be associated with a reduction in all - cause mortality in NAFLD patients, but the impact on cardiovascular disease mortality is not obvious. These findings indicate that increasing dietary niacin intake may be beneficial for NAFLD patients, but further research is still needed to confirm its long - term effects.